Reticle Biosystems, Inc.
New Form D on file · 2026-07-14 · the record
What the record says
Everything on the record so far — 2025-10-17 to 2026-09-24. This window lengthens as filings accumulate; it is not yet a year. 330 filings in Manufacturing, totalled by week. The dot is this raise, $1M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Use of proceeds, as written on the filing
The proceeds of the offering will be used for general working capital purposes, which may include the payment of salaries to executive officers in the ordinary course of business.
Company officers on record
James Che is named as Executive Officer and Director and Promoter on the Form D that Reticle Biosystems, Inc. filed with the SEC on 14 July 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-07-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Reticle Biosystems, Inc.
- Source Check — verify James Che's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with James Che for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Reticle Biosystems, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Reticle Biosystems, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.